www.fdanews.com/articles/61694-gilead-inks-hiv-drug-distribution-deal-with-merck
GILEAD INKS HIV DRUG DISTRIBUTION DEAL WITH MERCK
August 14, 2006
Gilead Sciences Inc. agreed to a manufacturing and distribution deal for the HIV drug Atripla with Merck & Co. Foster City-based Gilead will make the tablets a combination of three HIV drugs in one pill using one of the drugs, efavirenz, supplied by Merck. The other two components are Gilead drugs. Merck will then distribute the tablets in developing countries.
Yahoo Finance